The role of the renin-angiotensin system in the development of cardiovascular disease

American Journal of Cardiology

Volumn 89, Issue 2 SUPPL. 1, 2002, Pages 3-9

  Unger, Thomas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RECEPTOR SUBTYPE;

ANGIOTENSIN BLOOD LEVEL; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DISEASE COURSE; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME METABOLISM; HEART INFARCTION; HEART PROTECTION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; INCIDENCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TISSUE GROWTH; TISSUE REPAIR; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0037165229     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02321-9     Document Type: Conference Paper

References (38)

1. Preclinical pharmacology of angiotensin II receptor antagonists: Update and outstanding issues
2. 2 receptors
3. International Union of Pharmacology. XXIII. The angiotensin II receptors
4. Angiotensin II receptors and angiotensin II receptor antagonists
5. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
6. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats
7. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
8. Beyond blood pressure: New roles for angiotensin II
9. Angiotensin receptors
10. Angiotensin II receptor blockade and end-organ protection: Pharmacological rationale and evidence
11. 2) receptor promotes axonal regeneration in the optic nerve of adult rats
12. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction
13. Changes in skin angiotensin II receptors in rats during wound healing
14. 1 receptor: Gain-of-function study using gene transfer
15. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin
16. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure
17. Effects of losartan on hemodynamic parameters and angiotensin receptor mRNA levels of rat heart after myocardial infarction
18. Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study
19. 1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves
20. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: A workshop consensus statement
21. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress
22. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog
23. Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents
24. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
25. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats
26. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade
27. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats
28. The importance of left ventricular hypertrophy in human hypertension
29. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: A review
30. Hypertension as a risk factor for cardiac events: Epidemiologic results of long-term studies
31. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
32. Oxidative stress and vascular damage in hypertension
33. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
34. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia
35. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
36. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme
37. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
38. 1 receptor antagonism, ACE inhibition and combined treatment. Effects on mortality, functional and morphological parameters after experimental myocardial infarction in stroke prone SHRs